Succimer

From WikiMD's Medical Encyclopedia

(Redirected from DMSA)

Information about Succimer[edit]

Succimer is an oral heavy metal chelating agent used to treat lead and heavy metal poisoning.


Liver safety of Succimer[edit]

Succimer has been linked to a low rate of transient serum aminotransferase elevations during therapy, but its use has not been linked to cases of clinically apparent liver injury with jaundice.


Mechanism of action of Succimer[edit]

Succimer (sux’ i mer) or dimercaptosuccinic acid (DMSA) is an orally available heavy metal chelating agent that is used to treat lead poisoning in children. Succimer is an organo-sulfur compound with two sulfhydryl groups that bind divalent metal ions such as lead, cadmium, mercury, and arsenic. Succimer does not significantly chelate essential metals such as zinc, copper or iron, and its specificity, safety and oral availability make it preferable to other chelating agents for treating lead poisoning such as Ca-EDTA which must be given intravenously and dimercaprol (British anti-Lewisite [BAL]) which requires intramuscular administration. Succimer has been shown to lower blood lead levels and improve symptoms of chronic lead poisoning.

FDA approval information for Succimer[edit]

Succimer was approved for use in the United States in 1991, and current indications are for treatment of lead poisoning in pediatric patients with plasma lead levels above 45 µg/dL. It is used off label to treat adults with lead poisoning and for therapy of arsenic and mercury intoxication. Succimer is also used in naturopathic medicine as a part of chelation therapy for various conditions.

Dosage and administration for Succimer[edit]

Succimer is available in capsules of 100 mg generically and under the brand name Chemet. The recommended dose is 10 mg/kg (or 30 mg/m2) every 8 hours for 5 days, with 2 week rest periods between repeated courses if lead levels remain high.

Side effects of Succimer[edit]

Side effects are generally mild and may include headache, nausea, anorexia, diarrhea, rash and renal dysfunction. Uncommon, but potentially severe adverse events include hypersensitivity reactions.


Arsenic Chelators

Copper Chelators (for Wilson Disease)

Iron Chelators

Lead Chelators

Mercury Chelators

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.